Nephrosphere Lab

Dr. Jochen Reiser & The suPAR Journey

At the forefront of kidney research, The Nephrosphere Lab at The University of Texas Medical Branch (UTMB) is redefining how we understand, diagnose, and treat kidney disease. Under the leadership of Dr. Jochen Reiser, an internationally recognized physician-scientist, the lab brings together innovation, discovery, and clinical impact to transform patient care.

A Transformative Discovery: The suPAR Story

One of the most groundbreaking contributions from Dr. Reiser and collaborators is the identification of soluble urokinase plasminogen activator receptor (suPAR) as a key factor in kidney disease. What began as a scientific question evolved into a paradigm-shifting discovery—linking suPAR to the development and progression of chronic kidney disease (CKD) and focal segmental glomerulosclerosis (FSGS).

This work has:

  • Advanced understanding of kidney disease mechanisms
  • Enabled earlier risk detection and stratification
  • Opened new pathways for targeted therapies
  • Positioned suPAR as a powerful biomarker with global clinical relevance
  • The “suPAR journey” reflects years of rigorous science, collaboration, and persistence—bridging bench research to bedside application

Where Purpose Meets Passion

Current Projects

Slide to see more

Meet the Team

Current Members

Alumni